Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound glycyrrhizin tablets for childhood asthma
ChiCTR2000032644Phase 4Recruiting
- Sponsor
- University of Chinese Academy of Sciences Shenzhen Hospital
- Start
- May 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of glycyrrhizinate in asthma (2 arms), sponsored by University of Chinese Academy of Sciences Shenzhen Hospital. Primary endpoints: Asthma control rate, Expression of Th17 cells in venous blood and 2 more. Started May 2020; status: recruiting.
02
Drugs
glycyrrhizinate
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR2000032644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032644.